Table 4.

Day 1 and day 7 characteristics of participants completing the trial per protocol

Characteristics	Test Day	Placebo	APE	GE	RLE	ANE
N (Male/Female)		17 (9/8)	15 (7/8)	15 (6/9)	17 (6/11)	17 (11/6)
Age (years)		46.7 ± 9.9	47.0 ± 9.3	52.7 ± 12.6	46.8 ± 8.2	48.4 ± 9.0
Body Weight (kg)	1	90.8 ± 14.7	91.0 ± 10.4	88.3 ± 15.1	86.3 ± 13.6	87.9 ± 9.7
	7	90.8 ± 14.7	91.1 ± 10.7	88.0 ± 15.3	86.3 ± 13.6	88.0 ± 9.6
BMI	1	30.2 ± 3.9	32.0 ± 1.8	30.8 ± 2.9	30.8 ± 3.5	30.4 ± 3.5
	7	30.1 ± 3.9	32.0 ± 1.9	30.7 ± 3.0	30.5 ± 3.4	30.4 ± 3.5
Total Cholesterol (mg/dL)	1	206 ± 41	183 ± 30	190 ± 46	196 ± 34	200 ± 46
	7	195 ± 44	170 ± 25	175 ± 35	191 ± 31	184 ± 35
LDL-C (mg/dL)	1	135 ± 42	116 ± 30	115 ± 42	123 ± 34	133 ± 43
	7	129 ± 43	107 ± 25	105 ± 29	117 ± 34	119 ± 35
HDL-C (mg/dL)	1	50.3 ± 18.1	51.0 ± 17.2	58.7 ± 17.2	57.8 ± 17.7	50.1 ± 12.5
	7	48.2 ± 19.4	46.3 ± 13.5	55.4 ± 19.8	54.8 ± 19.2	46.8 ± 11.2
TG (mg/dL)	1	97.5 ± 39.8	96.7 ± 39.8	101.7 ± 38.7	102.3 ± 35.8	111.1 ± 46.8
	7	95.8 ± 36.2	94.7 ± 26.4	90.3 ± 23.8	102.1 ± 57	103.8 ± 40.4

There were no statistically significant differences in any of the measured anthropometric or serum lipids between groups at day 1 or at day 7. Results are Mean ± SD